BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16159691)

  • 1. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine.
    Sharma RP; He Q; Riley RT
    Toxicology; 2005 Dec; 216(1):59-71. PubMed ID: 16159691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice.
    He Q; Sharma RP
    Toxicon; 2005 Sep; 46(4):404-13. PubMed ID: 16054185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride.
    He Q; Kim J; Sharma RP
    Toxicology; 2005 Feb; 207(1):137-47. PubMed ID: 15590129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases.
    He Q; Kim J; Sharma RP
    Toxicol Sci; 2004 Aug; 80(2):335-42. PubMed ID: 15103051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice.
    Bhandari N; He Q; Sharma RP
    Toxicology; 2001 Aug; 165(2-3):195-204. PubMed ID: 11522378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of IFN-gamma reduces fumonisin-induced hepatotoxicity in mice via alterations in inflammatory cytokines and apoptotic factors.
    Sharma RP; He Q; Johnson VJ
    J Interferon Cytokine Res; 2003 Jan; 23(1):13-23. PubMed ID: 12639295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1.
    Sharma RP; Bhandari N; He Q; Riley RT; Voss KA
    Toxicology; 2001 Feb; 159(1-2):69-79. PubMed ID: 11250056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of sphingoid base 1-phosphate as a potential contributor to hepatotoxicity in fumonisin B1-exposed mice.
    Kim DH; Lee YS; Lee YM; Oh S; Yun YP; Yoo HS
    Arch Pharm Res; 2007 Aug; 30(8):962-9. PubMed ID: 17879749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor.
    Sharma RP; Bhandari N; Riley RT; Voss KA; Meredith FI
    Toxicology; 2000 Feb; 143(2):183-94. PubMed ID: 10755704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
    Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
    Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
    He Q; Riley RT; Sharma RP
    Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of selected cell signaling genes in mouse liver by fumonisin B1.
    Bhandari N; Raghubir P ; Sharma
    Chem Biol Interact; 2002 Mar; 139(3):317-31. PubMed ID: 11879819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumonisin B1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling.
    Osuchowski MF; Edwards GL; Sharma RP
    Neurotoxicology; 2005 Mar; 26(2):211-21. PubMed ID: 15713342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of fumonisin B1 hepatotoxicity in mice by depletion of T cells with anti-Thy-1.2.
    Sharma N; He Q; Sharma RP
    Toxicology; 2006 Jun; 223(3):191-201. PubMed ID: 16690192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
    Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
    J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.
    Suzuki H; Riley RT; Sharma RP
    Toxicology; 2007 Jan; 229(1-2):42-53. PubMed ID: 17095132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
    He Q; Riley RT; Sharma RP
    Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of CD95-ligand and other apoptotic signaling factors by fumonisin B1, a hepatotoxic mycotoxin, in livers of mice lacking tumor necrosis factor alpha.
    Sharma RP; He Q; Johnson VJ; Voss KA
    Cytokine; 2003 Dec; 24(5):226-36. PubMed ID: 14596819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-adenosylmethionine or 5'-methylthioadenosine are unable to prevent fumonisin B1 hepatotoxicity in mice despite increased oxidation in liver.
    He Q; Suzuki H; Sharma RP
    J Appl Toxicol; 2006; 26(6):509-16. PubMed ID: 17080400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks.
    Tardieu D; Tran ST; Auvergne A; Babilé R; Benard G; Bailly JD; Guerre P
    Chem Biol Interact; 2006 Mar; 160(1):51-60. PubMed ID: 16412405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.